Immunology

fotonoticia 20260622172129 1920

AbbVie acquires Apogee Therapeutics for 9.5 billion to strengthen its immunology business

The American pharmaceutical group AbbVie has announced the purchase of the biotechnology company Apogee Therapeutics for approximately 10.9 billion dollars (around 9.5 billion euros). With this operation, the company aims to strengthen and expand its catalog of treatments in the field of immunology.The agreement contemplates the acquisition of 100% of...

5 minutos

Most read

Hola, soy Fren. ¿Cómo te ayudo?